Unknown PHASE1 INTERVENTIONAL 2-arm NCT01640002

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

Sponsor: Hospital Universitário Professor Edgard Santos

Conditions Overactive Bladder Associated With HTLV-1

Interventions Placebo Propantheline Bromide

Updated 5 times since 2017 Last updated: Jul 12, 2012 Started: May 31, 2012 Primary completion: Oct 31, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Overactive Bladder Associated With HTLV-1, this trial is ongoing. The trial is conducted by Hospital Universitário Professor Edgard Santos and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitário Professor Edgard Santos

Data source: Hospital Universitário Professor Edgard Santos

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salvador, Brazil